Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-01-06FDA Approved: TOPIRAMATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved Heritage Pharmaceuticals' supplemental application for Topiramate Sprinkle, a generic version of topiramate. The product is man…
-
FDA approval · 2017-01-06FDA Approved: PHENYTOIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for phenytoin from Rising Pharma Holdings, Inc., indicating an update related to the generic antisei…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)
Completed clinical trial evaluating eslicarbazepine acetate as add-on therapy to a single baseline antiepileptic drug for epilepsy (ESLADOBA…
-
FDA approval · 2017-01-04FDA Approved: LEVETIRACETAM — Original Application (Eugia US LLC)
FDA approved a generic injectable form of levetiracetam in saline (LEVETIRACETAM IN SODIUM CHLORIDE) under an Original Application by Eugia …
-
FDA approval · 2016-12-27FDA Approved: PHENYTEK — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for PHENYTEK (extended phenytoin sodium) from Mylan Pharmaceuticals Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-26Clinical Trial Update: Cardiac Arrhythmias in Epilepsy: the CARELINK-study [NA]
The CARELINK-study, sponsored by Stichting Epilepsie Instellingen Nederland, investigated cardiac arrhythmias in epilepsy and has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Refractory Epilepsy [NA]
This entry notes an ongoing clinical trial evaluating deep brain stimulation of the anterior nucleus of the thalamus for refractory epilepsy…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy [Phase 3]
Phase 3 trial assessing safety and tolerability of intravenous carbamazepine in adults with epilepsy completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures [Phase 3]
A Phase 3 trial evaluating lamotrigine extended-release added to existing seizure therapies in patients with partial-onset seizures has comp…
-
FDA approval · 2016-11-30FDA Approved: LAMOTRIGINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for Lamotrigine from Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS safety_alert · 2016-11-25Clinical Trial Update: Risk of Urinary Retention With Retigabine
A terminated GlaxoSmithKline-sponsored trial evaluating retigabine in epilepsy has raised concerns about urinary retention. The update highl…
-
CLINICAL_TRIALS trial_result · 2016-11-25Clinical Trial Update: Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial [Phase 3]
Open-label extension update for a Phase 3 trial in epilepsy evaluating VRX-RET-E22-301; results posted after trial completion.
-
CLINICAL_TRIALS research · 2016-11-21Clinical Trial Update: Big Data Construction and Biological Etiological Epidemiology Study of Children Epilepsy in China
An update on an ongoing Chinese clinical trial investigating pediatric epilepsy through big data construction and biological etiological epi…
-
CLINICAL_TRIALS trial_result · 2016-11-09Clinical Trial Update: Special Drug Use Investigation for LAMICTAL® (Long Term)
A long-term Special Drug Use Investigation of LAMICTAL (lamotrigine) for epilepsy has completed. The sponsor is GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2016-11-09Clinical Trial Update: Drug Use Investigation for LAMICTAL
A completed clinical trial investigating Lamictal (lamotrigine) for epilepsy under a drug use investigation has finished.
-
FDA approval · 2016-11-08FDA Approved: GABAPENTIN — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for gabapentin submitted by BluePoint Laboratories.
-
FDA approval · 2016-11-08FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc., resulting in changes to the …
-
FDA approval · 2016-11-08FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2016-11-08FDA Approved: GABAPENTIN — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's supplemental application for gabapentin (ANDA078428).
-
FDA label_change · 2016-11-04FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approves a supplemental application for Cerebyx (fosphenytoin sodium) from Pfizer Laboratories Div Pfizer Inc, updating labeling.
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Intermittent Fasting in Refractory Epilepsy [Phase 2]
A Phase 2 trial evaluating intermittent fasting for refractory epilepsy has been terminated.
-
FDA approval · 2016-11-02FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
FDA approved a Supplemental Application for Depakote Sprinkles (divalproex sodium) submitted by AbbVie Inc.
-
FDA approval · 2016-11-02FDA Approved: VIMPAT — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for VIMPAT (lacosamide) from UCB, Inc., resulting in an update to its labeling for epilepsy-related …
-
FDA approval · 2016-11-02FDA Approved: DEPAKOTE — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote (divalproex sodium) from AbbVie Inc. The action updates labeling or indications related…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of levetiracetam for controlling partial seizures, with or without secondary gen…